IRIS
DI PASQUA, LAURA GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.171
AS - Asia 2.007
EU - Europa 1.569
SA - Sud America 291
Continente sconosciuto - Info sul continente non disponibili 152
AF - Africa 118
OC - Oceania 6
Totale 8.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.990
CN - Cina 763
SG - Singapore 454
IE - Irlanda 416
HK - Hong Kong 263
VN - Vietnam 254
RU - Federazione Russa 251
IT - Italia 211
BR - Brasile 208
DE - Germania 169
FR - Francia 118
FI - Finlandia 112
CA - Canada 96
GB - Regno Unito 65
IN - India 59
ZA - Sudafrica 45
BD - Bangladesh 37
UA - Ucraina 34
BE - Belgio 33
JP - Giappone 33
SE - Svezia 33
AR - Argentina 30
CZ - Repubblica Ceca 28
MX - Messico 24
EC - Ecuador 20
ID - Indonesia 20
PL - Polonia 19
NG - Nigeria 18
ES - Italia 15
CO - Colombia 14
IQ - Iraq 14
PH - Filippine 14
HN - Honduras 13
PK - Pakistan 13
TR - Turchia 13
IL - Israele 11
NI - Nicaragua 11
NL - Olanda 10
SA - Arabia Saudita 9
GT - Guatemala 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
CR - Costa Rica 7
EG - Egitto 7
MY - Malesia 7
TN - Tunisia 7
DK - Danimarca 6
LT - Lituania 6
UZ - Uzbekistan 6
CM - Camerun 5
JM - Giamaica 5
JO - Giordania 5
KR - Corea 5
RO - Romania 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
ET - Etiopia 4
HR - Croazia 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
AU - Australia 3
DZ - Algeria 3
GH - Ghana 3
LV - Lettonia 3
PR - Porto Rico 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CD - Congo 2
CI - Costa d'Avorio 2
CL - Cile 2
GR - Grecia 2
IM - Isola di Man 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
TG - Togo 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
BG - Bulgaria 1
BI - Burundi 1
BW - Botswana 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
HU - Ungheria 1
KZ - Kazakistan 1
Totale 8.151
Salva come PNG Salva come JPEG
Città #
Chandler 456
Dublin 413
San Jose 379
Ashburn 362
Hong Kong 254
Beijing 243
Singapore 218
Council Bluffs 216
Dallas 196
Los Angeles 133
Boardman 88
Lauterbourg 82
New York 80
Helsinki 74
Hanoi 73
Ho Chi Minh City 71
Shanghai 71
Munich 69
Moscow 68
Princeton 66
Lawrence 64
Medford 61
Nanjing 51
Jacksonville 49
Wilmington 45
Pavia 43
Santa Clara 42
Ann Arbor 38
Johannesburg 38
Milan 35
San Francisco 35
Buffalo 33
Orem 33
Tokyo 33
Atlanta 32
Redondo Beach 32
Brussels 30
Montreal 30
Hebei 25
Brooklyn 23
Changsha 22
Turku 22
Brno 21
Nanchang 20
São Paulo 20
Denver 19
Seattle 19
Toronto 19
Columbus 18
Hangzhou 18
The Dalles 18
Warsaw 18
London 17
Chicago 16
Da Nang 16
Haiphong 15
Houston 15
Tianjin 15
Chennai 14
Frankfurt am Main 14
Shenyang 14
Jiaxing 12
Mexico City 12
Phoenix 12
Rome 12
Cagliari 11
Düsseldorf 10
Managua 10
Monza 10
Naples 10
Berlin 9
Brasília 9
Lagos 9
Poplar 9
Quito 9
Charlotte 8
Fairfield 8
Baghdad 7
Boston 7
Des Moines 7
Falkenstein 7
Falls Church 7
Guayaquil 7
Nuremberg 7
Port Harcourt 7
Thái Nguyên 7
Amsterdam 6
Dhaka 6
Guangzhou 6
Guatemala City 6
Memphis 6
Paris 6
Philadelphia 6
Rio de Janeiro 6
San José 6
Washington 6
Ankara 5
Belo Horizonte 5
Biên Hòa 5
Bogotá 5
Totale 5.057
Salva come PNG Salva come JPEG
Nome #
Rauwolfia vomitoria (Apocynaceae): A comprehensive insight into its botany, ethnomedicinal uses, pharmacology, phytochemistry, and clinical trials 789
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 185
Changes in serum levels of asymmetric-dimethylarginine (ADMA) in a rat model of non-alcoholic steatohepatitis: Role of oxidative stress 178
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 157
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 152
Metabolic shift in liver: correlation between perfusion temperature and hypoxia inducible factor-1α. 149
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 142
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 140
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 139
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 132
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 129
Fluorescing fatty acids in rat fatty liver models 127
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 127
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 126
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 125
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 122
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 120
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 115
Fluorescence excitation properties of bilirubin in solution and in serum 113
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 112
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 112
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 109
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 108
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 108
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 108
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 106
Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion 104
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 104
Immobilized amyloid Aβ peptides support platelet adhesion and activation 101
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 101
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 100
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 97
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma 96
Liver injury and changes in biliary, tissue and serum levels of Asymmetric Dimethylarginine: role of Obeticholic Acid, a Farnesoid X Receptor agonist. 96
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 96
Changes in glutathione content in liver diseases: An update 96
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 96
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 93
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 93
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 93
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 92
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 91
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 89
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 88
Autofluorescence detection of liver oxidative damage products 87
SerpinB3 administration protects liver against ischemia-reperfusion injury 86
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 86
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 83
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 83
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 83
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 82
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 82
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 81
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 80
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 78
Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH 77
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 76
MPEP administration reduces steatosis and inflammation in ob/ob mice 76
Targeting mitochondrial complex I modulates lipid metabolism, inflammation and hepatic fibrosis in a MCD-diet model of benign steatosis 75
MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis 75
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 75
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 75
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 74
MCD Diet Modulates HuR and Oxidative Stress-Related HuR Targets in Rats 73
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 73
Mitochondrial Complex I modulator (CIM) reduces lipid accumulation and inflammation in MCD-diet fed rats 71
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 69
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 67
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 67
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 65
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH 63
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 63
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 61
Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management 60
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 58
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 53
Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries 45
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 45
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 41
Complex I Modulator BI4500 Reduces MASH by Limiting Oxidative Stress and Reprogramming Lipid Metabolism via AMPK in MCD Rats 31
Molecular Targets in Liver Disease 21
The Proline-Rich Tyrosine Kinase Pyk2 Regulates Platelet Activation and Microvascular Thrombosis in a Model of Low-Grade Endotoxemia 18
Totale 8.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022313 0 0 0 0 7 6 4 26 5 11 101 153
2022/20231.207 138 112 12 136 59 128 1 58 489 12 49 13
2023/2024480 78 54 23 24 39 83 49 30 1 20 31 48
2024/20251.270 26 86 22 21 20 92 102 38 332 76 157 298
2025/20263.000 203 168 327 313 398 141 552 118 281 241 95 163
2026/20271.489 271 264 427 317 210 0 0 0 0 0 0 0
Totale 8.314